Brazilin Inhibits Bladder Cancer by Downregulating KIF20A-Mediated Mitotic Pathway
International Journal of Molecular Sciences · 19.11.2026 · 27 (22) · 10385
DOI: 10.3390/ijms272210385 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 19.11.2026. Verfasst von Lili Zhao und 15 weiteren Autor:innen. Die Arbeit nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Shanxi Key R&D project, Fundamental Research Program of Shanxi Province.
Abstract (Originalsprache)
Bladder cancer is the 10th most common cancer worldwide, with high recurrence rates and limited therapeutic options for chemoresistant cases. Brazilin, a natural homoisoflavonoid from Caesalpinia sappan L., exhibits antitumor activity, but its mechanism in bladder cancer remains largely unknown. This study aimed to investigate whether brazilin exerts anti-bladder cancer effects through mitotic catastrophe and to identify the key molecular target involved. Label-free quantitative proteomics was performed on T24 and 5637 bladder cancer cells treated with brazilin, followed by GO/KEGG enrichment and protein–protein interaction network analyses. Key findings were validated by live-cell imaging, Western blot, immunofluorescence, qRT-PCR, and TUNEL assays. KIF20A was overexpressed or knocked out in T24 cells, and orthotopic mouse models were established to confirm the in vivo mechanism. Proteomics identified KIF20A as a significantly downregulated hub protein. Brazilin induced DNA damage, suppressed DNA repair, disrupted mitotic spindle assembly, and arrested cells in mitosis, ultimately triggering mitotic catastrophe. KIF20A overexpression promoted cell proliferation and migration, while knockout suppressed these effects. Brazilin showed the strongest inhibitory effects in KIF20A-overexpressing cells, and in vivo, it inhibited tumor growth most effectively in KIF20A-overexpressing tumors. These findings demonstrate that brazilin suppresses bladder cancer growth by downregulating KIF20A and inducing mitotic catastrophe, establishing KIF20A as a critical functional mediator and providing a mechanistic rationale for targeting the mitotic pathway in bladder cancer therapy.
Förderung
- National Natural Science Foundation of China
- Shanxi Key R&D project
- Fundamental Research Program of Shanxi Province
- Science and Education Cultivation Fund of the National Cancer and Regional Medical Center of Shanxi Provincial Cancer Hospital
- Chinese International Science Exchange Foundation ‘Biomedical Innovation and Development Research Project’
- Traditional Chinese Medicine Research Project of Shanxi Provincial Health Commission
Zitieren
APA
Zhao, L., Jiang, Y., Chen, L., Sun, Q., Yang, Y., Wang, J., Yan, L., Zhang, Y., Huang, Z., Chen, S., Yang, Y., Li, J., Xu, J., Wang, B., Han, X., & Yang, X. (2026). Brazilin Inhibits Bladder Cancer by Downregulating KIF20A-Mediated Mitotic Pathway. International Journal of Molecular Sciences, 27(22), 10385. https://doi.org/10.3390/ijms272210385
Vancouver
Zhao L, Jiang Y, Chen L, Sun Q, Yang Y, Wang J, et al. Brazilin Inhibits Bladder Cancer by Downregulating KIF20A-Mediated Mitotic Pathway. International Journal of Molecular Sciences. 2026;27(22):10385. doi:10.3390/ijms272210385
BibTeX
@article{Zhao2026,
author = {Zhao, Lili and Jiang, Yuchen and Chen, Lixia and Sun, Qili and Yang, Yongming and Wang, Jing and Yan, Lei and Zhang, Yiyin and Huang, Ziyang and Chen, Simin and Yang, Yuxin and Li, Junjun and Xu, Jinhua and Wang, Binxuan and Han, Xuebing and Yang, Xihua},
title = {Brazilin Inhibits Bladder Cancer by Downregulating KIF20A-Mediated Mitotic Pathway},
journal = {International Journal of Molecular Sciences},
year = {2026},
volume = {27},
number = {22},
pages = {10385},
doi = {10.3390/ijms272210385}
}
EUVIMED